Table 1.
Stimulant Group | |
---|---|
Total subjects | 12 |
Gender | |
Male/Female | 7/5 |
Mean Age when stimulant started (range) | 10.5 years (59 - 255 months) |
Median Duration of time on stimulants (range) | 24.5 months (2 month - 90 months) |
Brain Involvement | |
Left/Right/Bilateral | 7/2/3 |
Symptoms | |
Seizures | 12 (100%) |
Hemiparesis | 8 (67%) |
Headaches | 8 (67%) |
Visual Field Deficit | 6 (50%) |
Additional Medications | |
Aspirin | 9 (75%) |
Oxcarbazepine | 6 (50%) |
Carbamezipine | 3 (25%) |
Valproic Acid | 3 (25%) |
Levitiracetam | 2 (17%) |
Lamotrigine | 1 (8%) |
Topiramate | 1 (8%) |
Felbamate | 1 (8%) |